Connect
MJA
MJA

In This Issue

Med J Aust 2003; 179 (2): .
Published online: 21 July 2003

Arach attack

One for spider fetishists and phobics: how bad can a redback spider bite get and how should we be giving antivenom (if at all)? Isbister and Gray followed up patients from across Australia to find out (→ Latrodectism: a prospective cohort study of bites by formally identified redback spiders).

Foxglove fashions

Digoxin, obtained from the leaves of the foxglove, has had a chequered career as a therapeutic agent since at least the 18th century. New agents, different drug combinations and apparently variable trial results late last century led to some uncertainty about its role in heart failure and arrhythmias. Campbell and MacDonald prime us on the latest evidence-based recommendations for digoxin use in the early 21st century (→ Digoxin in heart failure and cardiac arrhythmias).

A pain in the north

For those who believe the root cause of pain on Sydney's North Shore is its real estate prices, read on. Blyth and colleagues surveyed over 2000 residents in the Northern Sydney Health Area to assess the prevalence, causes and impact of chronic pain in that community (→ Chronic pain-related disability and use of analgesia and health services in a Sydney community).

GP genetics

Knowledge about genetic testing is another string newly added to the GP's bow. In our continuing series on The New Genetics, Mann covers what a genetics-friendly GP might need to discuss in a consultation (→ The general practitioner and the "new genetics").

Activate editorials

Physical inactivity and cardiovascular disease are common themes in this issue's editorials. How should Australia tackle these problems? We could enlist more GPs for starters, say Smith et al (→ Physical activity is important, but can it be promoted in general practice?).

Woodward and Reid put the spotlight on the recent World Health Report, which shows the scourge of wealthy countries — cardiovascular disease — creeping up the list of causes of death and disability in developing countries. They describe current initiatives directed towards achieving maximal benefit at minimal cost in these countries (→ Cardiovascular disease in the Asia-Pacific region: challenges for health research and policy).

Venous thromboembolism triggered by factors such as short-term immobility seldom recurs. But should people at higher risk of unprovoked recurrence be on long-term, low-intensity warfarin? Eikelboom and Hankey give us the answers from a recent randomised controlled trial (→ Long-term management of venous thromboembolism: is there a role for low-intensity warfarin therapy?).

More trial reports

The baseline characteristics of participants usually appear in reports of clinical trials, but why bother mentioning them at all? Burgess and colleagues continue our EBM: Trials on trial series with the rationale for reporting baseline data, as well as how to interpret and use them (→ Baseline data in clinical trials). In the other arm of our series, Doyle reports on a real-life trial of indomethacin on long-term outcomes for tiny babies (→ Indomethacin and long-term outcome for tiny babies).

Troppo over troponin

Regarded as the best thing since the cardiac equivalent of sliced bread, troponins have rapidly replaced CK-MB in the chemical diagnosis of myocardial damage. Troponins have a different activity profile though, and the timing of the test differs from that of CK-MB. Davey audited requests for troponin assays in three Melbourne hospitals to see how well the tests were being used (→ Troponin testing: an audit in three metropolitan hospitals).

Terminating angst

Two women's hospitals created committees to approve late terminations after a controversial termination of pregnancy later than 20 weeks' gestation was reported to the Victorian Coroner. But is "decision by committee" the way to go when it comes to such complex cases? What's more, whose interests will these committees serve? In "Termination review committees: are they necessary?", Woodrow debates the ethical implications of having such committees.

Town and country

What makes a GP opt for a country practice? Laven and colleagues conducted a case-control study of over 2000 rural and urban GPs to find out (→ Factors associated with rural practice among Australian-trained general practitioners).

The city-country divide can seem like a chasm when comparing super-specialised metropolitan teaching hospitals with rural hospitals. Hore and colleagues discuss what may be a more relevant approach to providing specialist cover for rural critical care, which requires skills ranging from anaesthesia to retrieval (→ Integrated critical care: an approach to specialist cover for critical care in the rural setting).

Another time ... another place...

Throughout the ages man has been intent on maintaining some control over his reproductive potential, and his efforts in attempting to induce abortion have continued unabated . . . Only by careful history taking, with direct and specific questioning, can the "interference" factor be assessed . . .

Jones WR (MJA 1966; 1: 1017-1019)



Correspondence: 

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.